We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Fancy Dress Worldwide is a fancy dress online retailer founded in March 2016 and has already achieved more than 380,000 orders in 80 countries, with revenues over £1.6m in Year 2 and growing rapidly. The company carries out software processes in-house and has grown from 1 staff member to 25. They have also increased their product range from 1 item to 20,000 products, which has resulted in moving to larger premises twice in two years.
days to go: Expired investment: £313,557
Ubiqutek is pioneering the use of electricity in the weed control market. http://ubiqutek.com/ 
days to go: Expired investment: £133,065
Cadello is a newly produced category-defining unique spirit produced by Distilleria Pisoni, a 150-year-old distillery in Italy. It is growing its distributors over the UK as well as Italy. The company has also partnered with Honest Grapes and other independent marketers and sales teams. Cadello has hired Italian and UK Brand Ambassadors and engaged Pegasus Spirits as UK importer and brand manager. The company will support its continued fast-paced growth by investing into its marketing and sales through tradeshows & tasting events, Brand Ambassadors, PR (editorial and events), social media & advertising, and bartending competitions.
days to go: Expired investment: £275,490
HUUB is a premium endurance sports apparel brand. Its products are used by Olympic gold medallists, 'IRONMAN' champions and amateur athletes. HUUB witnessed profits worth £4.8 million and an EBITDA of £420,000 in 2019. The company is a leading brand in the £60 million UK triathlon apparel & accessories market. HUBB is now targeting the US$5 billion global bike apparel market. It has built working relationships with noteworthy individuals such as former Olympian Greg Whyte and chef Gordon Ramsay. The company will use the investment to target all endurance sports through a combination of retail and distributor partnerships. It will also expand its Direct-To-Consumer (DTC) online business.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,352,941
Photocrowd is a photograph community that connects photographers with one another. It also provides a platform for these photographers to earn money from their best photographs. Photocrowd currently have 31,000 members signed up in 166 different countries. 
days to go: Expired investment: £595,620
Occuity seeks to develop revolutionary non-invasive screening and monitoring devices for chronic diseases like diabetes and Alzheimer's. It argues that its device safely shines a low power beam of light into the eye and then collects and analyses the return signal to accurately measure structures within the eye and detect changes associated with the onset of the aforementioned diseases. Occuity is targeting three distinct markets, namely Ophthalmology, Disease Screening and Disease Monitoring, which is worth an estimated $35 billion per year. It claims that its 'Occuity Indigo' product enables earlier detection of diabetes and provides a non-contacting, pain-free glucose monitor. Occuity was awarded over £1.5 million as part of the Innovate UK grant for the development of technology within Occuity Indigo. It has also signed a partnership with one of the UK's leading ophthalmic distributors, Birmingham Optical, to distribute its PM1 pachymeter device. It states it will use 42% of the investment towards Research and Development (R&D), 23% towards sales and marketing, 20% towards management and finance, 9% towards managing CAPEX and NRE, and 6% towards paying fees.
days to go: Expired investment: £2,854,857
Maecenas is a fine art investment platform, allowing collectors to raise funds and investors to own a piece of fine art they would not normally be able to afford such as a picasso or even a Rembrandt! The investment made in the Artwork can easily be re-sold using the Maecenas platform and all investments are fully protected by insurance and a strong legal framework. 
days to go: Expired investment: £218,249
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph